Obstela 5 mg
| SKU | 2625 |
|---|---|
| Generic For | Ocaliva |
| Manufacturer | Sun Pharmaceuticals Ltd |
| Active Ingredient | Obeticholic Acid |
Out Of Stock
Obstela 5 mg (Obeticholic Acid) – Affordable Ocaliva Alternative
What is Obeticholic Acid and what condition does it treat?
Obeticholic Acid is a farnesoid X receptor (FXR) agonist used primarily to treat primary biliary cholangitis (PBC), a chronic liver disease that damages bile ducts. Marketed under the brand name Obstela 5 mg among others, this prescription medication helps improve liver function in adults with PBC who have an inadequate response to ursodeoxycholic acid or cannot tolerate it. As a bile acid analogue, Obeticholic Acid works by reducing the buildup of toxic bile acids in the liver, slowing disease progression and improving biochemical markers associated with liver inflammation and damage.
How does Obeticholic Acid work in the body?
Obeticholic Acid functions as a potent FXR agonist, activating the farnesoid X receptor which plays a crucial role in bile acid regulation. When you take Obstela 5 mg, the active ingredient binds to FXR receptors in liver cells, triggering a cascade that reduces bile acid production, enhances bile acid transport out of liver cells, and decreases inflammation. This mechanism helps protect liver tissue from toxic bile acid accumulation seen in primary biliary cholangitis. By modulating bile acid metabolism and reducing hepatic inflammation, this liver disease medication addresses the underlying biochemical imbalances rather than just symptoms.
How long does Obstela 5 mg take to work?
Obstela 5 mg typically shows measurable improvements in liver biochemistry markers within three to six months of consistent treatment. Most patients with primary biliary cholangitis see reductions in alkaline phosphatase levels—a key indicator of liver damage—within the first 12 weeks, though optimal therapeutic benefits may take six months or longer. The timeline varies based on individual disease severity and response to therapy. This PBC medication works gradually to reduce liver inflammation and bile acid toxicity, so patience with the treatment course is essential. Regular blood tests help your healthcare provider monitor Obeticholic Acid effectiveness throughout your treatment journey.
When and how should I take Obstela 5 mg?
Take Obstela 5 mg once daily, preferably at the same time each day to maintain consistent blood levels of Obeticholic Acid. You can take this liver disease medication with or without food, though taking it with a meal may help reduce potential stomach upset. Swallow the tablet whole with water—do not crush, chew, or split it. If you're also taking bile acid binding resins like cholestyramine for cholesterol, take Obstela at least four hours before or after those medications, as they can interfere with absorption. Always follow your doctor's prescribed dosing schedule, especially regarding titration instructions, as dosage may be adjusted based on your liver function and treatment response.
Is Obstela 5 mg safe for long-term use?
Obstela 5 mg is designed for long-term therapy in managing primary biliary cholangitis, a chronic progressive liver condition. Clinical studies demonstrate that Obeticholic Acid can be used safely over extended periods when appropriately monitored, with many patients taking this PBC medication for years. Long-term safety requires regular liver function testing and monitoring for potential side effects like itching or lipid changes. The medication's safety profile in ongoing treatment is well-documented, though individual tolerance varies. Your healthcare provider will conduct periodic blood work to assess liver enzymes, bilirubin levels, and lipid profiles, ensuring the therapeutic benefits continue to outweigh any risks throughout your treatment course.
Can I take Obstela 5 mg with other medicines?
Obstela 5 mg can interact with certain medications, so medication review is essential before starting treatment. Bile acid sequestrants like cholestyramine or colesevelam can reduce Obeticholic Acid absorption—take them at least four hours apart. Warfarin and other anticoagulants may require closer INR monitoring when combined with this PBC treatment, as bile acid changes can affect vitamin K absorption. CYP enzyme-inducing drugs might alter effectiveness. Many patients safely take Obstela alongside ursodeoxycholic acid and routine medications for blood pressure, diabetes, or cholesterol when properly managed. Always inform your pharmacist and doctor about all prescription drugs, over-the-counter products, and supplements you're taking to prevent potentially harmful interactions.
How does Obstela 5 mg compare to similar medicines in its class?
Obstela 5 mg containing Obeticholic Acid is currently the only FXR agonist approved for treating primary biliary cholangitis, making direct comparisons within its class challenging. Unlike ursodeoxycholic acid (UDCA), the first-line PBC therapy that replaces toxic bile acids with a more benign version, Obeticholic Acid actively regulates bile acid production and transport through receptor activation. This liver disease medication is typically prescribed when UDCA alone proves inadequate or cannot be tolerated. Some patients use both therapies together for synergistic benefits. Compared to emerging PBC treatments in development, Obstela has the most extensive clinical data and established efficacy profile for improving alkaline phosphatase levels and slowing disease progression.
Is the generic Obeticholic Acid as effective as branded versions?
Generic Obeticholic Acid contains the identical active pharmaceutical ingredient as branded Obstela 5 mg and must meet stringent bioequivalence standards set by regulatory agencies like the FDA, Health Canada, and the TGA. These standards ensure generic versions deliver the same therapeutic effect, safety profile, and blood concentration levels as the original brand-name medication. Both generic and branded forms of this PBC treatment undergo rigorous quality testing and contain 5 mg of the FXR agonist per tablet. The primary differences lie in inactive ingredients, packaging, and price—not clinical effectiveness. Many patients successfully manage primary biliary cholangitis with generic versions, achieving comparable improvements in liver function markers at significantly lower costs.
Why do patients choose PremiumRxDrugs for Obstela 5 mg?
Patients consistently choose PremiumRxDrugs for Obstela 5 mg because of our commitment to authenticity, affordability, and convenience in managing chronic liver conditions like primary biliary cholangitis. As a licensed pharmacy operating for over ten years, we provide manufacturer-sourced Obeticholic Acid at competitive prices, making long-term PBC treatment more accessible. Our discreet packaging respects patient privacy, while worldwide shipping with free delivery options serves customers across the USA, UK, Australia, Canada, and beyond. The streamlined prescription management system simplifies medication reordering—crucial for patients requiring continuous therapy. Combined with reliable customer support and a proven track record, PremiumRxDrugs offers the confidence and convenience patients need when purchasing specialist liver disease medications online.
What are the common side effects of Obeticholic Acid?
The most common side effect of Obeticholic Acid is pruritus (itching), experienced by many patients taking this bile acid medication for primary biliary cholangitis. Other frequent reactions include fatigue, abdominal pain or discomfort, joint pain, dizziness, and constipation. Some patients notice changes in lipid levels, with increased LDL cholesterol or decreased HDL cholesterol during treatment. Thyroid function changes have also been reported. Most side effects are mild to moderate and often improve as your body adjusts to the FXR agonist therapy. Severe itching can sometimes require dose adjustment or additional medications to manage symptoms. If you experience yellowing skin, dark urine, or worsening fatigue, contact your healthcare provider promptly as these may indicate liver-related concerns.
Who should avoid taking Obeticholic Acid?
Obeticholic Acid is contraindicated in patients with complete biliary obstruction, as this bile acid analogue requires functioning bile ducts to work safely. People with decompensated cirrhosis or Child-Pugh Class B or C liver disease should avoid this medication due to increased risk of liver-related complications. Pregnant women should not use Obeticholic Acid, as it may harm the developing fetus; effective contraception is essential during treatment for women of childbearing potential. Breastfeeding mothers should discuss alternatives, as it's unknown whether this FXR agonist passes into breast milk. Those with a history of hypersensitivity to Obeticholic Acid or any tablet components should avoid this PBC medication. Always disclose your complete medical history to ensure safe prescribing.
Login
Sign Up
Login
Sign Up